Have a complex challenge with an ADC or bioconjugate?
Contact Us

Simplifying bioconjugate & ADC development 

Our full-service offering for bioconjugates/ADCs provides you with:  

  • Drug product development and manufacturing services
  • Tailored drug intermediate manufacturing
  • Process and analytical development
  • Drug substance manufacturing
  • Formulation development

All under one quality system supported by global regulatory services and writing support.

You need to pace and manage investments in the different phases of the development cycle and offer flexible business models to help meet your specific program needs. Our scientists and engineers bring a decade of development experience across a broad spectrum of both platform and novel conjugation technologies.

We manufacture the majority of commercial ADC therapeutics, which are approved in 60+ countries

The next generation of pharmaceuticals

Antibody-Drug Conjugates represent an innovative therapeutic application that combines the unique properties of mAbs with the potent cell killing activity of cytotoxic small molecule drugs.

Services geared to enable the commercialization of your drug candidate

We have a successful track record of marketed bioconjugates. 

Our experience spans a broad range of technologies including:

  • Antibodies conjugated to nanoparticles (TNPs) and non-cytotoxic drugs (including peptides)
  • Radio-immunoconjugates (mAb conjugated to chelating agents)
  • Vaccines (haptens conjugated to carrier proteins)
  • PEGylation and cross-linking
  • ADCs

One of the first CDMOs to support the commercialization of bioconjugates

Our highly experienced regulatory affairs team can support your project at all stages of the development lifecycle from concept to commercialization. This experience allows us to advise you on developing your regulatory and submission strategies, preparing you for success.
service
Process Definition and Sample Preparation
Lonza has experience with many platform and novel bioconjugation technologies to support drug discovery activities. Learn about our process definition services today
service
Process Development and Optimization
Lonza's biopharmaceutical & small molecule expertise helps develop, scale-up & optimize processes for ADC manufacturing. Learn about our bioconjugation services.
service
Formulation Development
Lonza Drug Product Services considers the interplay between solubility, local tolerance & systemic toxicity for parenteral small molecule programs. Learn more.
service
Analytical Services
Find out about Lonza's analytical capabilities for ADC manufacturing. Go from concept to commercial, with Lonza - learn more.
service
Targeting Agent and Carrier Protein
Lonza has vast experience in expressing, developing and manufacturing recombinant proteins as bioconjugate targeting agents/carrier proteins. Learn more
service
Drug Substance Manufacturing
At Lonza we support the manufacture of various bioconjugates including high potency ADCs for clinical & commercial supply. Learn more
service
Drug Product Manufacturing
Lonza's Drug Product Services manufacture GMP liquid and lyophilized drug product batches for clinical and commercial supplies, non-GMP batches, stability studies. Learn more

Bioconjugation (Visp, CH)

Drug product services (Basel, CH)


Related Content


Our GS Xceed® Gene Expression System has options to engineer and express conjugation-competent antibodies. Applications include antibody-drug conjugates (ADCs), half-life extension and imaging.

Unlike other contract development and manufacturing organizations (CDMOs), we are in the unique position to offer complete development and manufacturing services from both mammalian cell culture and advanced chemical synthesis for the production of Antibody-Drug Conjugates (ADCs). From process development to manufacturing scale-up, we are proud to offer more ways than ever to deliver your product.

View recent articles on complex protein expression
Learn from Lonza Experts on complex protein expression, download recent articles here.
service
ADC Payload Product Development
Lonza offers tailored services to fit your specific ADC development plan, with expertise in antibodies, payloads and bioconjugation. Learn how we can help.
technology
Chemical Synthesis Technologies
We provide integrated chemical synthesis services for small molecules, from initial route scouting to commercial-scale process intensification. See how Lonza can support your goals.
technology
GS Xceed® Expression System
Learn about our GS Xceed® Expression System; a robust, integrated, scalable mammalian expression platform producing recombinant therapeutic proteins.

Visp, Switzerland

Production, Research & Development, Sales & Support

Visp 3930
Switzerland